Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-065799
Filing Date
2025-07-03
Accepted
2025-07-03 16:31:22
Documents
4
Effectiveness Date
2025-07-03

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2519000d1_s8.htm S-8 84077
2 EXHIBIT 5.1 tm2519000d1_ex5-1.htm EX-5.1 6375
3 EXHIBIT 23.2 tm2519000d1_ex23-2.htm EX-23.2 2751
4 EX-FILING FEES tm2519000d1_ex-filingfees.htm EX-FILING FEES 11665
  Complete submission text file 0001104659-25-065799.txt   106272
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288520 | Film No.: 251105971
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)